These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35329408)

  • 1. Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.
    Awadu JE; Sikorskii A; Zalwango S; Coventry A; Giordani B; Ezeamama AE
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children.
    Awadu JE; Zalwango SK; Sikorskii A; Giordani B; Bovin MJ; Musoke PM; Ezeamama AE
    Medicine (Baltimore); 2023 Jan; 102(4):e32677. PubMed ID: 36705393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In utero/peripartum antiretroviral therapy exposure and mental health outcomes at 8-18 years old: A longitudinal comparative study of children with perinatally acquired HIV, children perinatally HIV exposed but uninfected, and children unexposed uninfected from Uganda.
    Coventry A; Sikorskii A; Zalwango SK; Familiar-Lopez I; Cardino VN; Giordani B; Ezeamama AE
    Res Nurs Health; 2024 Apr; 47(2):195-207. PubMed ID: 38031814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.
    Ezeamama AE; Zalwango SK; Sikorskii A; Tuke R; Musoke PM; Giordani B; Boivin MJ
    HIV Med; 2021 Aug; 22(7):592-604. PubMed ID: 33860626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and Probability of Developmental Disorders among Perinatally HIV-Affected and Unaffected Ugandan Children.
    Awadu JE; Giordani B; Sikorskii A; Abbo C; Fenton JI; Zalwango S; Ezeamama AE
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
    Jao J; Bonner LB; Dobinda K; Powis KM; Sun S; Legbedze J; Mmasa KN; Makhema J; Mmalane M; Kgole S; Masasa G; Moyo S; Gerschenson M; Mohammed T; Abrams EJ; Kurland IJ; Geffner ME
    Clin Infect Dis; 2024 Sep; 79(3):727-733. PubMed ID: 38531012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Vitamin D is Differentially Associated with Socioemotional Adjustment in Early School-Aged Ugandan Children According to Perinatal HIV Status and In Utero/Peripartum Antiretroviral Exposure History.
    Yakah W; Fenton JI; Sikorskii A; Zalwango SK; Tuke R; Musoke P; Boivin MJ; Giordani B; Ezeamama AE
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopment of children who are HIV-exposed and uninfected in Kenya.
    Bulterys MA; Njuguna I; King'e M; Chebet D; Moraa H; Gomez L; Onyango A; Malavi K; Nzia G; Chege M; Neary J; Wagner AD; Lawley KA; Wamalwa D; Benki-Nugent S; John-Stewart G
    J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26149. PubMed ID: 37909174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children.
    Benki-Nugent SF; Yunusa R; Mueni A; Laboso T; Tamasha N; Njuguna I; Gómez L; Wamalwa DC; Tapia K; Maleche-Obimbo E; Bangirana P; Boivin MJ; John-Stewart GC
    J Acquir Immune Defic Syndr; 2022 Apr; 89(4):441-447. PubMed ID: 35202050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
    J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
    Leroy V; Ekouevi DK; Becquet R; Viho I; Dequae-Merchadou L; Tonwe-Gold B; Rouet F; Sakarovitch C; Horo A; Timité-Konan M; Rouzioux C; Dabis F;
    PLoS One; 2008 Feb; 3(2):e1645. PubMed ID: 18286200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
    McIntyre JA; Hopley M; Moodley D; Eklund M; Gray GE; Hall DB; Robinson P; Mayers D; Martinson NA
    PLoS Med; 2009 Oct; 6(10):e1000172. PubMed ID: 19859531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.
    Vrouenraets SM; Wit FW; Garcia EF; Huber M; Brinkman K; Moyle G; Domingo P; Tarr PE; Podzamczer D; Ristola M; Gatell JM; Livrozet JM; Furrer H; Reiss P;
    HIV Clin Trials; 2012; 13(2):103-10. PubMed ID: 22510357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Language outcomes of preschool children who are HIV-exposed uninfected: An analysis of a South African cohort.
    Green F; du Plooy C; Rehman AM; Nhapi RT; Lake MT; Barnett W; Hoffman N; Zar HJ; Donald KA; Stein DJ; Wedderburn CJ
    PLoS One; 2024; 19(4):e0297471. PubMed ID: 38598467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), and Nevirapine (NVP) (CAS Nos. 30516-87-1, 134678-17-4, 129618-40-2) in Genetically Modified C3B6.129F1-Trp53(tm1Brd) N12 Haploinsufficient Mice (in utero and postnatal gavage studies).
    National Toxicology Program
    Natl Toxicol Program Genet Modif Model Rep; 2013 Oct; (16):1-236. PubMed ID: 24503698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.